sorafenib has been researched along with Choroid Neovascularization in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abbate, I; Apicella, I; Bucolo, C; D'Agata, V; De Falco, S; Giuliano, F; La Rosa, LR; Maugeri, G; Mazzone, MG; Platania, CBM; Santonocito, M; Solfato, E; Tarallo, V; Viola, S; Zappulla, C | 1 |
Liu, YL; Wang, JL; Wang, ZH; Xi, Y; Zhang, Q | 1 |
Byeon, SH; Chung, EJ; Koh, HJ; Lee, JH; Lim, HJ; Yoo, S | 1 |
Lee, YC; Park, YH; Roh, SY | 1 |
Kampik, A; Kernt, M; Neubauer, AS; Staehler, M; Stief, C | 1 |
5 other study(ies) available for sorafenib and Choroid Neovascularization
Article | Year |
---|---|
Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
Topics: Administration, Ophthalmic; Animals; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Emulsions; Female; Male; Mice; Mice, Inbred C57BL; Nanostructures; Protein Kinase Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Neovascularization; Sorafenib | 2021 |
Combination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenib.
Topics: Animals; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Fundus Oculi; Humans; Liposomes; Male; Niacinamide; Oligopeptides; Phenylurea Compounds; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Inbred BN; Receptors, Immunologic; Sorafenib; Vascular Endothelial Growth Factor A | 2013 |
Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Benzenesulfonates; Blotting, Western; Choroidal Neovascularization; Dextrans; Dose-Response Relationship, Drug; Female; Fluoresceins; Mice; Mice, Inbred C57BL; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2009 |
Effect of sorafenib on experimental choroidal neovascularization in the rat.
Topics: Animals; Benzenesulfonates; Choroidal Neovascularization; Computer Systems; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Fluorescein Angiography; Gene Expression; Intercellular Adhesion Molecule-1; Lasers; Male; Niacinamide; Phenylurea Compounds; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyridines; Radiation Injuries; Rats; Rats, Inbred BN; Sorafenib; Vascular Endothelial Growth Factor A | 2010 |
Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment.
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Choroidal Neovascularization; Humans; Macular Edema; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2008 |